Moderna Could Seek Approval in November
Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities https://t.co/dTBLH3iwbT
— The Washington Post (@washingtonpost) October 22, 2020
Health Editor’s Note: The main issues other than safety and efficacy is that the vaccine/trials will be representative of the U.S. population. Recruitment has slowed the process but now there are 30,000 participants with 25% over 65, one fifth Hispanic, and 10% Black.
Pfizer, which is not a part of the Operation Warp Speed, a federal program to speed up COVID-19 vaccine research and production, also has a large trial in the works with 39,862 participants. Both the Moderna and Pfizer trials have given the second booster dose of vaccine…..Carol
Carol graduated from Riverside White Cross School of Nursing in Columbus, Ohio and received her diploma as a registered nurse. She attended Bowling Green State University where she received a Bachelor of Arts Degree in History and Literature. She attended the University of Toledo, College of Nursing, and received a Master’s of Nursing Science Degree as an Educator.
She has traveled extensively, is a photographer, and writes on medical issues. Carol has three children RJ, Katherine, and Stephen – one daughter-in-law; Katie – two granddaughters; Isabella Marianna and Zoe Olivia – and one grandson, Alexander Paul. She also shares her life with her husband Gordon Duff, many cats, and two rescues.